GP Surgeries in North Central London Launch Mobile Services

iPLATO HealthcarePatients of GP practices in North Central London including Enfield, Barnet, Haringey, Camden and Islington will soon start receiving appointment reminders and health information via text message. Already in use by a large number of practices in the area this service aims to improve patient access to GP services, reduce unnecessary visits to A&E as well as informing patients about important NHS services such as cancer screening and seasonal flu immunisation.

North Central London NHS Cluster has committed to fund participating surgeries across the Boroughs to use iPLATO Patient Care Messaging for the next three years. With 91% of the UK adult population owning a mobile phone (77% in the 65-74 age group) surgeries can reach a significant number of their patients through this service. Text messages are free to receive for the patient. If they have a smartphone such as iPhone, Blackberry or Android patients will also be able to access information about their local health services via their mobile phone.

Dr. Janet High GP at the Park Lodge Medical Centre, one of the current existing practice said, "Mobile phones are used by most of our patients and so text messaging is an effective way to communicate with them. This service has the potential to significantly increase the number of patients attending clinics as well as saving on surgery administration costs."

Patients who choose to respond to text reminders or access the smartphone service will be charged standard operator rates depending on their individual contract. Patients can opt out of the service at any time by contacting their surgery.

To benefit from these services patients are encouraged to hand in their mobile phone number to their practice. If patients have already their mobile phone number recorded with their GP they will receive a text message to let them know that the service is running as part of service launch.

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company dedicated to mobile health since 2006.

iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with healthcare professionals and provider organisations, support patients in achieving longer, healthier lives.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...